Development and Evaluation of an internet-based Intervention fo the reduction of posttraumatic stress and anxiety symptoms in former pediatric cancer patients

Development and Evaluation of an internet-based Intervention fo the reduction of posttraumatic stress and anxiety symptoms in former pediatric cancer patients - Onko-STEP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000653

Enrollment

Registered

2011-01-20

Start date

2011-05-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F43.1 F40

Interventions

Group 1: Internet-based treatment to cope with symptoms of posttraumatic stress symptoms and anxiety after pediatric cancer. There are 10 sessions (à approx. 55min) during a time-frame of 6 weeks. Par

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age at first cancer diagnosis =18 years - Stable remission of malignant disease (no acute treatment (chemotherapy, radiation or surgery), relapse or second malignancy during the last 6 month) - Clinically relevant symptoms of posttraumatic stress and/or anxiety - Fluent in written German - Internet access - No severe suicidal intentions or psychosis - Not be giving psychotherapeutic treatment elsewhere - No or stable psychopharmacological medication - Informed consent

Exclusion criteria

Exclusion criteria: Age < 15 years; acute treatment within the last 6 month; suicidal ideation and/or symptoms of acute psychosis

Design outcomes

Primary

Measure	Time frame
Primary Goal of the pilot projects is the testing of feasibility and acceptance as well as first pre/post evaluation in terms of a reduction of symptoms of posttraumatic stress and anxiety. Primary endpoints and methods (questionnaires): - Reduction of symptoms of posttraumatic stress, measured by use of the Posttraumatic Stress Diagnostic Scale (PDS) respectively the PTSD-Symptomscale for Children (K-PSS) - Reduction of anxiety symptoms, measured by use of the Anxiety scale of the Hospital Anxiety and Depression Scale – German Version (HADS) - Reduction of the fear of progression or relapse, measured by use of the Fear of Progression Questionnaire (PA-F) There are two assessments planned: At the beginning of the intervention and after compeletion (approx. 6 weeks).	—

Measure

Time frame

Primary Goal of the pilot projects is the testing of feasibility and acceptance as well as first pre/post evaluation in terms of a reduction of symptoms of posttraumatic stress and anxiety. Primary endpoints and methods (questionnaires): - Reduction of symptoms of posttraumatic stress, measured by use of the Posttraumatic Stress Diagnostic Scale (PDS) respectively the PTSD-Symptomscale for Children (K-PSS) - Reduction of anxiety symptoms, measured by use of the Anxiety scale of the Hospital Anxiety and Depression Scale – German Version (HADS) - Reduction of the fear of progression or relapse, measured by use of the Fear of Progression Questionnaire (PA-F) There are two assessments planned: At the beginning of the intervention and after compeletion (approx. 6 weeks).

—

Secondary

Measure	Time frame
Secondary outcome is the reduction of symptoms of depression, measured by the depression scale of the Hospital Anxiety and Depression Scale – German Version (HADS). There are also two points of assesment: At the beginning of the intervenetion and after completion (after approx. 6 weeks).	—

Countries

Germany

Contacts

Public ContactDiana Seitz

Universitätsklinikum Ulm, Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie

diana.seitz@uniklinik-ulm.de0731 500 61704

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026